BioSpace News Archive

Hesperos, Inc., announced today the receipt of a NIH Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Institute on Aging (NIA) to help create a new multi-organ “human-on-a-chip” model that can realistically mimic the biology of Alzheimer’s Disease (AD) and the effects of potential new therapies under realistic human physiological conditions.

Parker Laboratories, a worldwide leader in ultrasound products for more than 60 years, announced it has obtained the CE mark for UltraDrape™, the first combination sterile barrier and securement dressing for ultrasound-guided peripheral intravenous (UGPIV) insertions.

The kids are back to school, and now it’s time to get Back to YOU! That’s why Healthy For Life Meals is opening all 24 of its locations to anyone interested in learning more about its healthy, flexible meal service for its first-ever “Back to YOU” Event on September 6.

The Central and Southern Ohio chapter of the Healthcare Information and Management Systems Society (CSOHIMSS) announced its annual fall conference titled The Future of the Healthcare C-Suite

Nebula Genomics announced today that it has raised $4.3M million in seed financing with participation from 10 leading venture capital firms.

Independent study validates CL-7 technology as a more efficient way to purify crucial proteins.

According to the latest market research report released by Technavio, the global optical coherence tomography for ophthalmology market is expected to accelerate at a CAGR of almost 7% during the forecast period.

According to the latest market research report released by Technavio, the global cholera vaccines market is expected to accelerate at a CAGR of almost 10% during the forecast period.

Torigen Pharmaceuticals, a company focused on providing personalized cancer immunotherapies to the veterinary market, received the prestigious Innovation Award at the KC Animal Health Corridor Investment Forum in Kansas City, Mo.

Today the Grace Science Foundation (“GSF”) announced the creation of the world’s first and only NGLY1 Deficiency registry, which provides invaluable resources to the medical community racing to find a cure for this rare genetic disorder.